Stuart A Arbuckle is EVP, COO of VERTEX PHARMACEUTICALS INC . Currently has a direct ownership of 49,691 shares of VRTX, which is worth approximately $25.7 Million. The most recent transaction as insider was on Nov 16, 2020, when has been sold 7 shares (Common Stock) at a price of $223.29 per share, resulting in proceeds of $1,563. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 49.7K
0% 3M change
12.14% 12M change
Total Value Held $25.7 Million

Stuart A Arbuckle Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 16 2020
SELL
Open market or private sale
$1,563 $223.29 p/Share
7 Reduced 0.02%
35,179 Common Stock
Nov 03 2020
SELL
Open market or private sale
$329,469 $212.15 p/Share
1,553 Reduced 4.23%
35,179 Common Stock
Nov 03 2020
BUY
Exercise of conversion of derivative security
$134,366 $86.52 p/Share
1,553 Added 4.06%
36,732 Common Stock

Also insider at

RYTM
RHYTHM PHARMACEUTICALS, INC. Healthcare
IMGN
ImmunoGen, Inc. Healthcare
SAA

Stuart A Arbuckle

EVP, COO
Boston, MA

Track Institutional and Insider Activities on VRTX

Follow VERTEX PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRTX shares.

Notify only if

Insider Trading

Get notified when an Vertex Pharmaceuticals Inc insider buys or sells VRTX shares.

Notify only if

News

Receive news related to VERTEX PHARMACEUTICALS INC

Track Activities on VRTX